Skip to main content
. Author manuscript; available in PMC: 2006 Jul 4.
Published in final edited form as: Clin Cancer Res. 2005 Jun 15;11(12):4406–4414. doi: 10.1158/1078-0432.CCR-04-2181

Table 1.

Multivariate survival analysis of MPM tumors using a previously validated ratio-based prognostic test

Variable Hazard ratio (95% CI) P
Mixed (nonepithelial) cell type 1.49 (0.62-3.60) 0.37
Extrapleural lymph node metastasis 2.34 (0.77-7.16) 0.14
Positive resection margins 1.23 (0.33-4.65) 0.76
Prognostic test 2.00 (0.79-5.09) 0.14

NOTE: Hazard ratios and P values were generated by fitting a Cox proportional hazards regression model to censored survival data linked to specimens profiled in the current study (n = 39) as detailed in Materials and Methods. Clinical variables were converted to binary format and column codings used in multivariate analysis can be found in Supplemental Table S2. The “Prognostic test” variable refers to predictions made using a previously described (ref. 12) combination of three prognostic expression ratios according to criteria outlined in Results.

Abbreviation: 95% CI, 95% confidence interval.